The first two vaccines to reach the market were developed based on mRNA technology – a novel approach that triggers an autoimmune response without introducing any aspect of the virus itself. In this brief video we explore the science behind the innovation. Learn more about this innovative vaccine development platform: [ Ссылка ]
